Human Granzyme A Antibody, R&D Systems™

Granzyme A

Monoclonal

LYOPH

Immunoprecipitation 25 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready

P12544

GZMA

Mouse myeloma cell line NS0-derived recombinant human Granzyme A Cys26-Val262 Accession # P12544

100 μg

Primary

Detects human Granzyme A in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human Granzyme B, C, D, G, or H is observed.

Human

Purified

Immunoprecipitation, Flow Cytometry, Immunocytochemistry, CyTOF

356412

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CTL tryptase, CTLA3, CTLA3Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factorserine protease), Cytotoxic T-lymphocyte proteinase 1, EC 3.4.21, fragmentin-1, granzyme A, granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3), Granzyme-1, GZMA, H factor, Hanukkah factor, HF, HFSP, HFSPEC 3.4.21.78

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

3001

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b